Anna Katherina (Katja) Simon, PhD
Professor, University of Oxford, Former Grantee
Dr. Simon’s group is trying to understand the role of autophagy in immune cell fate mechanistically by identifying the autophagosomal cargo in vivo and during cell division and how autophagy in the microenvironment impacts on immune cells.
Sidhartha Sinha, MD
Assistant Professor, Stanford University, Current Grantee
The Sinha lab aims to develop novel solutions to alleviate intestinal inflammatory conditions. Their research is focused on understanding microenvironment changes to identify better therapeutic targets for people with GI immune-mediated disorders.
Jamie Spangler, PhD
Associate Professor, Johns Hopkins University, Current Grantee
The Spangler lab aims to expand the repertoire of protein therapeutics by redesigning naturally occurring proteins and engineering new molecules to overcome the deficiencies of existing drugs.
Hermann Steller, PhD
Professor, Rockefeller University, Former Grantee
Dr. Steller’s research focuses on how programmed cell death is regulated and how its dysfunction contributes to disease. They also study the nonlethal use of cell death proteins for cellular remodeling, and protein degradation in development, aging and disease.
Brigitta Stockinger, PhD
Professor, Francis Crick Institute, Former Grantee
The Stockinger lab focuses on how environmental factors influence processes in the body such as tissue repair and differentiation and immune cell functions. Malfunction in these processes can aid the development of inflammatory diseases and cancer.
Ronen Sumagin, PhD
Associate Professor, Northwestern University, Former Grantee
The Sumagin lab is exploring the roles of innate immune cells in regulating intestinal homeostasis, wound healing, host pathogen interactions and cancer development. They are using various approaches to study leukocyte trafficking in mucosal tissues.
